We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




AI Algorithm Detects 30% Of Breast Cancers Missed on MRI Scans

By HospiMedica International staff writers
Posted on 07 Nov 2024

In the United States, more than 500,000 women participate in supplemental breast magnetic resonance imaging (MRI) screenings each year. More...

These women are considered to be at an elevated risk for breast cancer. Following a negative screening mammogram, supplemental MRI can uncover an additional 15 to 18 cancers per 1,000 high-risk women. Thanks to the higher sensitivity of MRI compared to mammography, it may be feasible to estimate an individual's risk of developing cancer within the upcoming year based on their most recent negative screening MRI. Researchers have proposed that current MRI examinations contain valuable information regarding the outcome of the next annual screening. Based on this hypothesis, they have developed and assessed an artificial intelligence (AI) algorithm to identify breast cancer in MRI scans up to one year earlier than when radiologists typically detect it, potentially improving early detection among high-risk women.

A research team from The City College of New York (New York, NY, USA) fine-tuned a convolutional neural network (CNN) AI model, which was pre-trained on breast MRI data, utilizing a retrospective dataset that included 3,029 MRI scans from 910 patients. This dataset contained 115 cancers diagnosed within a year of a negative MRI result. The model aimed to identify these cancers to predict the development of cancer as much as one year in advance. The network was fine-tuned and validated using a 10-fold cross-validation method. The mean age of the patients involved was 52 years, ranging from 18 to 88 years, with an average follow-up duration of 4.3 years, spanning from 1 to 12 years.

The AI was able to detect cancers a year earlier, achieving an area under the ROC curve of 0.72. A retrospective review by a radiologist of the top 10% highest risk MRIs, as ranked by the AI, could have boosted early detection by up to 30%. The radiologist identified a visual marker for biopsy-proven cancers in 83 MRI scans from the previous year. The AI algorithm pinpointed the anatomical regions where cancer would be detected in 66 cases, with agreement between the two methods in 54 instances. Based on the findings published in Academic Radiology, the researchers concluded that their innovative AI-assisted re-evaluation of "benign" breast scans holds promise for enhancing early breast cancer detection through MRI. As datasets expand and image quality continues to improve, they anticipate that this method will become increasingly influential.


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Amplatzer Paraclose PVL Occluder is a minimally invasive device for paravalvular leak closure, offering an alternative to repeat open-heart surgery. (Photo courtesy of Abbott)

FDA Approves First Transcatheter Device for Paravalvular Leak Closure

Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences

Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.